Opko Health, Inc. (OPK: $7.25)
Bull Market Report Target Price: $13
Bull Market Report Sell Price: $8
Earnings Date: Tuesday, 4:30 PM ET
Consensus: 1Q17
Revenues: $313 M
EPS: -$0.04
Year Ago Quarter Results
Revenues: $290 M
EPS: -$0.02
Key Things to Watch For in the Quarter
Opko Health is expected to report 8% growth in revenues to $313 million and a earnings remaining flat with a tiny deficit for 1Q17. Year-after-year, Opko continues to reduce its operating loss and grow its top line, moving it closer to producing earnings. Opko beat analyst estimates in three of the past four quarters, and we expect them to continue this trend as they continue to minimize their losses. We strongly value our $13 price target as Opko continues to grow within the diagnostic and pharmaceutical segment of the healthcare industry.
And yes, we know that the stock is below our Sell Price. Tomorrow's announcement will be the key. The stock will either shoot to $8 or fall to $6.50. We trust it will be the former. If you are antsy, then get out tomorrow before the close. The stock hit $18 in 2015 and we don't see why the stock can't get to the $13-15 level later this year or next, as long as revenues keep increasing nicely like we have seen and like we expect.